当前位置: 首页 > 期刊 > 《医学新知杂志》 > 201110
编号:13760749
Rad51与癌症(4)
http://www.100md.com 2011年10月1日 《医学新知·综合版》 201110
     [19]韩为农,李虹,谢路鹭,等。人鼻咽癌与鼻咽cDNA阵谱中DNA修复相关表达差异的初步研究[J]。中华肿瘤杂志,2002,24(2):114-117

    [20]DoddLE,Sengupta S,Chen I,et al.Genes involved in DNA repair and nitrosam inemetabolism and those located on chromosome 14q32 are dyysregulated in nasopharyngeal carcinoma[J].Cancer Epidemiol Biomarkers Prev,2006,15(11):2216-2225

    [21]刘娜,周昕熙,卢丽霞,等。碱基切除修复基因在人类鼻咽癌组织和鼻咽非癌组织中的表达及其意义[J]。癌症,2008,27(2)126-132

    [22]Qiao GB,Wu YL,Yang XN,et al.High-level expression of Rad51 is an independent prognostic marker of survival in nonsmall-cell lung cancer patients[J].Br J Cancer,2005,93(1):137-143
, 百拇医药
    [23]Takenaka T,Yoshino I,Kouso H,et al.Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer[J].Int J Cancer,2007,121(4):895-900

    [24]乔贵宾,曾伟生,彭丽君,等。非小细胞肺癌组织Rad51高表达及其临床意义的研究[J]。中华肿瘤防治杂志,2009,16(14),1086-1100

    [25]Noguerira A,Catarino R,Coelho A,et al.Influence of DNA repair Rad51 gene variantsin overall surviants of non-small cell lung cancer patients treated with first line chemothereapy[J].Cancer Chemother Pharmacol,2009,66(3):501-506
, 百拇医药
    [26]Chuang SW,Wang LH,Hong JH,et al.Induction ofRab51 protein levels by P38 MAPK decreases cytotoxicity and mutagenicity in benzo[a] pyrene-exposerd human lung cancer cells[J].Toxicol Apple Pharmacol,2008,230(3):290-297

    [27]Ko JC,,Su YJ,Lin ST,et al.Suppression of ERCC1and Rad51 expression through ERK1/2 inactivationis essential in emhodin-mediated cytotoxicty in human non-small cell lung cancer cells[J].Biochem Pharmacol,2010,79(4):655-664
, 百拇医药
    [28]Wang Z,Dong H,Fu Y,et al.RAD51 135G>C polymorphism contributes to breast cancer susccptibility:a mela-analysis involving 26,444 subjects[J].Breast Cancer Res Treat,2010,124(3):765-769

    [29]Romanowicz-Makowska H,Smolarz B,Zadrozny M,et al.Analysis of RAD51 polymorphism and BRCA1 mutation in Polish women with breast cancer[J].Exp Oncol,2006,28(2):156-159

    [30]Antoniou A C,Sinilnikova O M,Simard J,et al.RAD51 135G-C modifies breast ceacer risk among BRCA2 mutation carriers results from a combined analysis of 19 studies[J].Am J Hum Genet,2007,81(6):1186-1200
, 百拇医药
    [31]Lose F,Lovelock P,Chenevix-Trench G,et al.Variation in the RAD51 gene and familial breast cancer[J].Breast Cancer Res,2006,8(3):R26

    [32]Nowacka-Zawisza M,Brys M,Romanowicz-Makowska H,et al.Dinucleotide repeat polymorphisms of RAD51 ,BRCA1,BRCA2 gene regions in breast cancer[J].Pathol Int,2008,58(5):275-281

    [33]Nowack-Zawisza M,Brys M,Romanowicz-Makowska H,et al.Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer[J].Cancer Detect Prev,2008,32(2):144-148
, 百拇医药
    [34]Krupa R,Synowiec E,Pawlowska E,et al.Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer[J].Exp Mol Pathol,2009,87(1):32-35

    [35]Soderlind K,Skoog L,Fomander T,et al.The BRCA1 BRCA2 RAD51 complex is a prognostic and predictive factor in early breast cancer[J].Radiother Oncol,2007,84(3):242-251

    [36]Hasselbach L,Haase S,Fischer D,et al.Characterisation of the promoter region of the human DNA-repair gene RAD51[J].Eur J Gynaecol Oncol,2005,26(5):589-598, 百拇医药(罗胜权(综述) 刘庚勋(审校))
上一页1 2 3 4 5下一页